HomeAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$30.23
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$30.23
Sarado: Peb 27, 5:52:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$29.98
Sakop ng araw
$29.01 - $30.52
Sakop ng taon
$22.24 - $45.99
Market cap
1.77B USD
Average na Volume
886.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 19.97M | 86.09% |
Gastos sa pagpapatakbo | 51.61M | -0.17% |
Net na kita | -108.04M | -11.93% |
Net profit margin | -541.09 | 39.85% |
Kita sa bawat share | -1.85 | -6.32% |
EBITDA | -120.31M | 2.72% |
Aktuwal na % ng binabayarang buwis | 0.93% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 854.42M | -4.40% |
Kabuuang asset | 1.30B | -22.00% |
Kabuuang sagutin | 104.11M | -14.83% |
Kabuuang equity | 1.19B | — |
Natitirang share | 58.59M | — |
Presyo para makapag-book | 1.47 | — |
Return on assets | -22.66% | — |
Return on capital | -23.73% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -108.04M | -11.93% |
Cash mula sa mga operasyon | -96.21M | 27.75% |
Cash mula sa pag-invest | 90.08M | 283.24% |
Cash mula sa financing | 2.56M | -47.19% |
Net change in cash | -3.58M | 97.98% |
Malayang cash flow | -62.05M | 42.58% |
Tungkol
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Itinatag
2008
Website
Mga Empleyado
540
